The company has a ROCE of 29.9 per cent and a ROE of 22.3 per cent.

Glenmark Pharmaceuticals Ltd is an innovation-driven global pharmaceutical company with a presence across Specialty, Generics and OTC businesses

This pharma company stock went 8 per cent high, do you own it?                                                                                                                                                                                                       With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.

India is positioned as a significant and rising player in the global pharmaceuticals sector. In August 2021, the Indian pharmaceutical market increased at 17.7 per cent annually, up from 13.7 per cent in July 2020. In this report, Shreya Chaware highlights the factors that will trigger further growth of this sector